Moderna
MRNA
#203
Rank
ยฃ84.07 B
Marketcap
ยฃ207.79
Share price
9.74%
Change (1 day)
1,003.81%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -ยฃ2.29 Billion

According to Moderna 's latest financial reports the company's current earnings are ยฃ2.21 Billion. In 2025 the company made an earning of -ยฃ2.06 Billion, an increase over its 2024 earnings that were of -ยฃ2.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ2.29 Billion11.32%
2025 -ยฃ2.06 Billion-23.03%
2024 -ยฃ2.67 Billion-8.22%
2023 -ยฃ2.91 Billion-140.65%
2022 ยฃ7.15 B-27.81%
2021 ยฃ9.90 B-1911.15%
2020 -ยฃ0.55 Billion44.7%
2019 -ยฃ0.38 Billion28.63%
2018 -ยฃ0.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ13.94 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ9.41 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ5.72 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ35.34 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ87.65 Million-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.11 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.90 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ0.12 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA